Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
Endocannabinoid signalling and the deteriorating brain.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Genetic variation associated with the occurrence and progression of neurological disorders.
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression.
Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery.
The Use of MiRNA Antagonists in the Alleviation of Inflammatory Disorders.
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Motor network efficiency and disability in multiple sclerosis.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis.
IV immunoglobulin confounds JC virus antibody serostatus determination.
Self-esteem is associated with perceived stress in multiple sclerosis patients.
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab.
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
Pages
« first
‹ previous
…
597
598
599
600
601
602
603
604
605
…
next ›
last »